ALA, EPA and DHA differentially Modulate Palmitate-induced Lipotoxicity through Alterations of its Metabolism and Storage in C12C12 Muscle Cells by Pinel, Alexandre et al.
 ALA, EPA and DHA differentially modulate palmitate-induced 
lipotoxicity through alterations of its metabolism and storage in 
C12C12 muscle cells. 
Pinel A., Rigaudière J-P., Laillet B., Malpuech-Brugère C., Morio B., Capel F. 
Institut National de la Recherche Agronomique, Université d’Auvergne, 
Clermont-Ferrand, France 
 
Since few decades, incidence of obesity and type 2 diabetes (T2D) is increasing. 
Excessive intake of energy leads to fat overload and formation of lipotoxic compounds 
mainly derived from the saturated fatty acid palmitate in insulin-sensitive tissues 
(muscle, liver and white adipose tissue), promoting insulin resistance (IR, a well-known 
metabolic disorder in T2D). Supplementation with n-3 fatty acids (n-3FA) is suggested 
to reduce lipotoxicity and IR. We hypothesized that, according to the n-3FA used, 
differential and specific effects on palmitate metabolism in muscle cells will be 
demonstrated. C2C12 myotubes were treated with 500 µM of palmitate without or with 
50 µM of alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA) or docosahexaenoic 
acid (DHA) for 16 hours and collected for measurement of membrane fluidity using 
diphenyl-hexatriene, ceramide content, insulin-dependent Akt protein phosphorylation 
(as an index of IR). The assessment of the intracellular metabolism and incorporation of 
palmitate into lipid fractions (triglycerides, phospholipids, diglycerides) was performed 
after treatment for 3 hours with [1-14C]-palmitate. As expected, palmitate-induced IR 
was restored by EPA and DHA supplementation whereas ALA had no effect compared 
to palmitate alone. EPA and DHA significantly improved C2C12 membrane fluidity 
compared to palmitate alone (+8.5% and +13% respectively, p<0.05). Furthermore, 
palmitate incorporation into the diglyceride fraction was decreased by 31 and 47% by 
EPA and DHA vs. palmitate, respectively (p=0.05). However, DHA significantly 
increased the ratio of diglycerides to total lipids vs. palmitate alone (p<0.05), whereas 
EPA did not. Finally, EPA was more potent to decrease palmitate-induced ceramide 
accumulation (+174%, p<0.05 vs. control) compared to DHA (-50% and -29% 
repectively, p<0.05). In conclusion and contrary to ALA, EPA and DHA treatment 
improved the insulin signalling pathway by differently modulating membrane fluidity and 
lipid and palmitate metabolism, thus demonstrating that n-3FA have different metabolic 
impacts on C2C12 lipid metabolism. 
